Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Kalehua Capital Management LLC
Form 13F · Q2 2026

Kalehua Capital Management LLC

CIK 2106181Filed 2026-08-1913F-HR/A View the filing on EDGAR ↗
$174M
Reported book value
26
Positions
3
Quarters on record
Top 50
Positions

Kalehua Capital Management LLC — holdings

Top 26 positions of 26, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1EA SERIES TRUST Ea Series Trust226,188+3.6%$26M15.2%
2MANE Veradermics Inc145,695+0.0%$18M10.3%
3XFOR X4 Pharmaceuticals Inc3.7M+0.0%$17M10.0%
4CMPS Compass Pathways Plc819,692+0.0%$12M6.7%
5SRZN Surrozen Inc385,178+0.0%$10M5.7%
6ACRS Aclaris Therapeutics Inc1.8M+0.0%$10M5.6%
7SION Sionna Therapeutics Inc197,072+0.0%$9M5.0%
8IKT Inhibikase Therapeutics Inc3.8M+0.0%$8M4.5%
9PHVS Pharvaris N V198,772+0.0%$7M4.0%
10KPTIQ Karyopharm Therapeutics Inc685,644—$7M3.9%
11SEPN Septerna Inc194,544+0.0%$7M3.7%
12INFLARX NV Inflarx Nv2.9M—$6M3.7%
13Cyclerion Therapeutics Inc Cyclerion Therapeutics Inc1.7M—$6M3.2%
14KRRO Korro Bio Inc405,040+270.3%$5M3.1%
15UNIQURE NV Uniqure Nv79,407−72.7%$4M2.1%
16LONA Leonabio Inc393,701+0.0%$4M2.1%
17DMRA Damora Therapeutics Inc139,000+0.0%$4M2.1%
18MLTX Moonlake Immunotherapeutics175,734+0.0%$3M2.0%
19ANL Adlai Nortye Ltd226,415—$3M1.5%
20TYRA Tyra Biosciences Inc74,465+0.0%$2M1.4%
21NVCT Nuvectis Pharma Inc100,000—$2M1.1%
22GOSS Gossamer Bio Inc11.1M+8.9%$2M1.1%
23MIST Milestone Pharmaceuticals In1.3M—$2M1.0%
24ATYR Atyr Pharma Inc1.8M—$1M0.6%
25TIL Instil Bio Inc99,600−45.6%$765,9240.4%
26TCRX Tscan Therapeutics Inc454,876—$445,8240.3%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.